Literature DB >> 32410223

Proctology in the COVID-19 era: handle with care.

I Giani1, C Elbetti1, M Trompetto2, G Gallo3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32410223      PMCID: PMC7273076          DOI: 10.1002/bjs.11676

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


× No keyword cloud information.
Editor The Italian outbreak of COVID-19 was confirmed on 31 January 2020 when two COVID-19-positive cases were reported in Chinese tourists. At the beginning, the vast majority of cases were reported in the northern regions of Italy with establishment of the so-called ‘red zone’. On 9 March 2020, the Italian prime minister declared a nationwide lockdown to strengthen the national health system (Sistema Sanitario Nazionale). Italy has one of the highest rates of infection and mortality in the world. Elective surgical procedures are postponed and only emergency care has been guaranteed. Proctology is one of the specialties most affected by concerns over the possibility of faecal transmission of the virus. Proctologic pathology has psychological components, including anxiety, stress and depression, especially in functional disorders. From the beginning of the COVID-19 outbreak, all patients scheduled for an outpatient clinic visit or surgical procedure have had a telephone interview and video consultation with their consent. Patients were assessed for urgency of diagnosis or treatment (medical history with a picture of the diseased area) and stratification of COVID-19 risk, according to modified Repici criteria. Based on these parameters, patients are scheduled for further telephone interview, outpatient clinic visit or surgery. Perianal or pilonidal abscesses, recurrent anal pain and selected cases of haemorrhoidal thrombosis are the only benign diseases considered for surgery, while suspected neoplasms are biopsied for histology and therapy. All patients scheduled for outpatient clinic visits are swab tested and considered free of infection after two negative reverse transcriptase–polymerase chain reaction (RT-PCR) tests for COVID-19. Patients with planned surgery have a thoracic CT 24–48 h before the procedure in addition to swab testing to exclude the disease. All our proctologic surgeries are performed in an outpatient setting with tailored local anaesthesia and adequate protective equipment both for patients and surgeon.
  5 in total

1.  Coronavirus pandemic and colorectal surgery: practical advice based on the Italian experience.

Authors:  S Di Saverio; F Pata; G Gallo; F Carrano; A Scorza; P Sileri; N Smart; A Spinelli; G Pellino
Journal:  Colorectal Dis       Date:  2020-06-01       Impact factor: 3.788

2.  COVID-19 pandemic: perspectives on an unfolding crisis.

Authors:  A Spinelli; G Pellino
Journal:  Br J Surg       Date:  2020-03-23       Impact factor: 6.939

Review 3.  Global guidance for surgical care during the COVID-19 pandemic.

Authors: 
Journal:  Br J Surg       Date:  2020-04-15       Impact factor: 6.939

4.  Italian society of colorectal surgery recommendations for good clinical practice in colorectal surgery during the novel coronavirus pandemic.

Authors:  G Gallo; M La Torre; R Pietroletti; F Bianco; D F Altomare; S Pucciarelli; G Gagliardi; R Perinotti
Journal:  Tech Coloproctol       Date:  2020-04-14       Impact factor: 3.781

5.  Coronavirus (COVID-19) outbreak: what the department of endoscopy should know.

Authors:  Alessandro Repici; Roberta Maselli; Matteo Colombo; Roberto Gabbiadini; Marco Spadaccini; Andrea Anderloni; Silvia Carrara; Alessandro Fugazza; Milena Di Leo; Piera Alessia Galtieri; Gaia Pellegatta; Elisa Chiara Ferrara; Elena Azzolini; Michele Lagioia
Journal:  Gastrointest Endosc       Date:  2020-03-14       Impact factor: 9.427

  5 in total
  5 in total

1.  Delayed benign surgery during the COVID-19 pandemic: the other side of the coin.

Authors:  M La Torre; F Pata; G Gallo
Journal:  Br J Surg       Date:  2020-05-22       Impact factor: 6.939

2.  Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes.

Authors:  Francesco Pata; Luigi Maria Bracchitta; Giancarlo D'Ambrosio; Salvatore Bracchitta
Journal:  J Clin Med       Date:  2021-12-31       Impact factor: 4.241

3.  Deadlock of proctologic practice in Italy during COVID-19 pandemic: a national report from ProctoLock2020.

Authors:  Gaetano Gallo; Alessandro Sturiale; Veronica De Simone; Gian Luca Di Tanna; Iacopo Giani; Ugo Grossi; Stefano Mancini; Giovanni Milito; Francesco Bianco; Roberto Perinotti; Domenico Aiello; Francesco Bianco; Andrea Bondurri; Gaetano Gallo; Marco La Torre; Giovanni Milito; Roberto Perinotti; Renato Pietroletti; Alberto Serventi; Marina Fiorino; Veronica De Simone; Ugo Grossi; Michele Manigrasso; Alessandro Sturiale; Gloria Zaffaroni; Ferruccio Boffi; Vittoria Bellato; Francesco Cantarella; Simona Deidda; Fabio Marino; Jacopo Martellucci; Marco Milone; Arcangelo Picciariello; Ana Minaya Bravo; Vincenzo Vigorita; Miguel Fernandes Cunha; Sezai Leventoglu; Tatiana Garmanova; Petr Tsarkov; Alaa El-Hussuna; Alice Frontali; Argyrios Ioannidis; Gabriele Bislenghi; Mostafa Shalaby; Felipe Celedon Porzio; Jiong Wu; David Zimmerman; Claudio Elbetti; Julio Mayol; Gabriele Naldini; Mario Trompetto; Giuseppe Sammarco; Giulio Aniello Santoro
Journal:  Updates Surg       Date:  2020-08-08

4.  Proctologic emergency consultation during COVID-19: Comparative cross-sectional cohort study.

Authors:  Rocío Maqueda Gonzalez; Carlos Cerdán Santacruz; Javier García Septiem; Lara Blanco Terés; Jose María Lopesino González; Guillermo Fernández Jiménez; Elena Martín-Pérez
Journal:  Cir Esp (Engl Ed)       Date:  2020-10-23

5.  A worldwide survey on proctological practice during COVID-19 lockdown (ProctoLock 2020): a cross-sectional analysis.

Authors:  Gaetano Gallo; Alessandro Sturiale; Veronica De Simone; Gian Luca Di Tanna; Iacopo Giani; Ugo Grossi
Journal:  Colorectal Dis       Date:  2020-10-27       Impact factor: 3.917

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.